The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells.
Jesridonin, a small molecule obtained through the structural modification of Oridonin, has extensive antitumor activity. In this study, we evaluated both its in vitro activity in the cancer cell line EC109 and its in vivo effect on tumor xenografts in nude mice. Apoptosis induced by Jesridonin was d...
Main Authors: | Cong Wang, Liping Jiang, Saiqi Wang, Hongge Shi, Junwei Wang, Ran Wang, Yongmei Li, Yinhui Dou, Ying Liu, Guiqin Hou, Yu Ke, Hongmin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4477902?pdf=render |
Similar Items
-
Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
by: Guiqin Hou, et al.
Published: (2014-01-01) -
Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma
by: Zhaoming Lu, et al.
Published: (2016-01-01) -
Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways
by: Zhen H, et al.
Published: (2020-12-01) -
Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma
by: Zhengqi Li, et al.
Published: (2021-09-01) -
Antitumor Efficacy and Mechanisms of Lapatinib in Combination with Cisplatin on Esophageal Squamous Cancer Cells
by: DOU Qiaohua, et al.
Published: (2019-09-01)